Recombinant Salmonella vectors in vaccine development
Curtiss, R.; Kelly, S.M.; Tinge, S.A.; Tacket, C.O.; Levine, M.M.; Srinivasan, J.; Koopman, M.
Developments in Biological Standardization 82: 23-33
1994
ISSN/ISBN: 0301-5149 PMID: 7958478 Document Number: 432926
A diversity of means are available for the attenuation of Salmonella which can be used to immunize animals and humans orally to elicit mucosal, humoral and cellular immune responses. Avirulent Salmonellae can be genetically engineered to express foreign antigens and the recombinant avirulent Salmonellae are capable of stable, high-level expression of the foreign antigen in the orally immunized animal or human host. The resulting vaccines are safe, efficacious, and are easy and economical to use.
Document emailed within 1 workday
Related Documents
Beliavskaia, V.A.; Timofeev, I.V.; Perminova, N.G.; Paletskaia, T.F.; Kozhina, E.M.; Zagrebel'nyĭ, S.N. 2000: Construction of an expression plasmid vector for accomplishing in vivo delivery of recombinant biologically active proteins. 2. Synthesis of HBcAG in a vaccine strain of Salmonella choleraesuis Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 3: 17-21Rice, C.M. 1990: Overview of flavivirus molecular biology and future vaccine development via recombinant DNA Southeast Asian Journal of Tropical Medicine and Public Health 21(4): 670-677
Peeters, B. 2008: Bird flu (avian influenza): applicable recombinant DNA techniques in research and vaccine development Tijdschrift Voor Diergeneeskunde 133(22): 956-958
Zanetti, F.; Rudak, L.; Micucci, M.ía.; Grand, D.C.; Luque, A.; Russo, S.; Taboga, O.; Pérez, O.; Calamante, G. 2012: Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate Revista Argentina de Microbiologia 44(2): 75-84
Maes, D.; Gibson, K.; Trigo, E.; Saszak, A.; Grass, J.; Carlson, A.; Blaha, T. 2001: Evaluation of cross-protection afforded by a Salmonella Choleraesuis vaccine against Salmonella infections in pigs under field conditions Berliner und Münchener Tierärztliche Wochenschrift 114(9-10): 339-341
Marakusha, B.I.; Petrovskaia, V.G.; Volkovoĭ, K.I. 1986: Isolation and characteristics of the biological and genetic properties of neamin-resistant mutants of Salmonella typhimurium and Salmonella dublin candidates for vaccine creation Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 3-8
Shrestha, A.; Gupta, S.K. 2014: Evaluation of immunogenicity and contraceptive efficacy of gamete-specific recombinant proteins for the development of contraceptive vaccine Journal of Reproductive Immunology 101-102: 46
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Teschendorf, C.; Warrington, K.H.; Shi, W.; Siemann, D.W.; Muzyczka, N. 2006: Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma Anticancer Research 26(1a): 311-317
Ferrer, M.F.; Zanetti, F.A.; Calamante, G. 2007: Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA) Revista Argentina de Microbiologia 39(3): 138-142
Sandhu, G.S.; Precup, J.W.; Kline, B.C. 1989: Rapid one-step characterization of recombinant vectors by direct analysis of transformed Escherichia coli colonies Biotechniques 7(7): 689-690
Dichek, D.A.; Anderson, J.; Kelly, A.B.; Hanson, S.R.; Harker, L.A. 1996: Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors Circulation 93(2): 301-309
Münch, S.; Wernery, U.; Kinne, Jörg.; Joseph, M.; Braun, P.; Pees, M.; Flieger, A.; Fruth, A.; Rabsch, W. 2013: Comparing the presence of different genes in Salmonella subspecies I-IV and development of a diagnostic multiplex PCR method for identification of Salmonella subspecies Berliner und Munchener Tierarztliche Wochenschrift 126(1-2): 16-24
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Małecki, M.; Swoboda, P.ł; Pachecka, J. 2009: Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy Acta Poloniae Pharmaceutica 66(1): 93-99
Pascual, D.W.; Powell, R.J.; Lewis, G.K.; Hone, D.M. 1997: Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine Behring Institute Mitteilungen 1997(98): 143-152
Mayr, A. 2001: Development of of non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine Berliner und Munchener Tierarztliche Wochenschrift 114(5-6): 184-187
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630